CNTG - Centogene GAAP EPS of -?1.19 revenue of ?47.5M

2023-05-17 01:56:13 ET

Centogene press release ( NASDAQ: CNTG ): FY GAAP EPS of -?1.19.

Revenue of ?47.5M (+12.6% Y/Y).

Significant expansion of gross profit margin from 32% to 42% and ongoing cost control resulted in significant improvement of net results

Both Pharma and Diagnostics segments positioned for strong performance in 2023, guidance of FY2023 total revenue growth between 10% to 15%

The Company expects revenue growth to be between 10 to 15% in FY2023 compared to FY2022.

The Company improved its net loss position by 31% at €31.8 million in FY2022 compared to a net loss of €46.2 million in FY2021.

The Company expects revenue growth to be between 10 to 15% in FY2023 compared to FY2022.

For further details see: